1. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma
- Author
-
Guang-Ji Wang, Jianping Lin, Ningjiang Shen, Liang Cheng, and Kang-Hua Li
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Bone Neoplasms ,Disease ,Real-Time Polymerase Chain Reaction ,Bone and Bones ,Metastasis ,Downregulation and upregulation ,Cox proportional hazards regression ,Biomarkers, Tumor ,medicine ,Overall survival ,Humans ,Prognostic biomarker ,RNA, Messenger ,Neoplasm Staging ,Osteosarcoma ,Reverse Transcriptase Polymerase Chain Reaction ,business.industry ,General Medicine ,Prognosis ,medicine.disease ,Gene Expression Regulation, Neoplastic ,Survival Rate ,MicroRNAs ,Case-Control Studies ,Lymphatic Metastasis ,Cancer research ,Biomarker (medicine) ,Female ,Neoplasm Grading ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
miRNA-22 (miR-22) has been showed to involve in a variety of cancers; however, the association between miR-22 expression level and the prognosis of osteosarcoma is also poorly unknown. Fifty-two patients with surgically resected paired osteosarcoma and non-neoplastic disease between 2008 and 2014 were involved in this study. Real-time PCR was performed to examine the expression level of miR-22 in osteosarcoma tissues and noncancerous bone tissues. Then the association between miR-22 expression and clinical-pathological parameters were further evaluated. Kaplan-Meier analysis and Cox proportional hazards regression models were explored to reveal the correlations of miR-22 expression with survival of patients. The results indicated that miR-22 was downregulated in osteosarcoma tissues in comparison with noncancerous bone tissues. In addition, there is statistically significance between miR-22 expression level and recurrence, metastasis, and chemotherapy response. The patients with lower miR-22 expression level had both poorer overall survival and disease-free survival. The multivariant analysis revealed that the miR-22 expression level and metastasis status are independent prognosis factors for osteosarcoma. In conclusion, miR-22 was downregulated in osteosarcoma and its expression level was correlated with a variety of important clinical-pathological parameters. Moreover, miR-22 may serve as a promising biomarker for predicting the prognosis of osteosarcoma.
- Published
- 2015